Skip to content
10-Q

Quarterly Report

CHINA PEDIATRIC PHARMACEUTICALS, INC.

0001017386-12-000392

← back to feed
Filed
Dec 19, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Dec 10, 2012 44.56M sh
Shares Diluted Q3 2012 · Sep 30, 2012 44.56M sh
Shares Diluted Q3 2012 · Sep 30, 2012 44.56M sh
Shares Diluted Q3 2012 · Sep 30, 2011 44.56M sh
Shares Diluted Q3 2012 · Sep 30, 2011 44.5M sh
Stockholders Equity Q3 2012 · Sep 30, 2012 $14.91M
Stockholders Equity restated Q3 2012 · Dec 31, 2010 $23.62M
Current Liabilities Q3 2012 · Sep 30, 2012 $1.59M
Current Liabilities Q3 2012 · Dec 31, 2011 $1.61M
Current Assets Q3 2012 · Sep 30, 2012 $14.17M
Current Assets Q3 2012 · Dec 31, 2011 $19.62M
Total Assets Q3 2012 · Sep 30, 2012 $16.5M
Total Assets Q3 2012 · Dec 31, 2011 $22.21M
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.08
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.13
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.11
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.15
Eps Basic Q3 2012 · Sep 30, 2012 −$0.08
Eps Basic Q3 2012 · Sep 30, 2012 −$0.13
Eps Basic Q3 2012 · Sep 30, 2011 −$0.10
Eps Basic Q3 2012 · Sep 30, 2011 −$0.02
Net Income Q3 2012 · Dec 31, 2011 −$6.97M
Net Income Q3 2012 · Sep 30, 2011 −$4.51M
Net Income Q3 2012 · Sep 30, 2011 −$731.81K
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$6M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $5.03M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $10.99M
Sga Expense restated Q3 2012 · Sep 30, 2011 $1.31M
Sga Expense restated Q3 2012 · Sep 30, 2011 $6.01M
Operating Income Q3 2012 · Sep 30, 2011 −$4.76M
Operating Income Q3 2012 · Sep 30, 2011 −$6.27M
Gross Profit Q3 2012 · Sep 30, 2011 $2.8M
Gross Profit Q3 2012 · Sep 30, 2011 $9.45M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $1.38M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $3.15M
Revenue Q3 2012 · Sep 30, 2011 $6.51M
Revenue Q3 2012 · Sep 30, 2011 $19.9M